Correlation Between Universal For and Memphis Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Universal For and Memphis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Universal For and Memphis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Universal For Paper and Memphis Pharmaceuticals, you can compare the effects of market volatilities on Universal For and Memphis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Universal For with a short position of Memphis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Universal For and Memphis Pharmaceuticals.

Diversification Opportunities for Universal For and Memphis Pharmaceuticals

0.18

Correlation Coefficient

Universal For  Memphis Pharmaceuticals

Average diversification

The 3 months correlation between Universal and Memphis is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Universal For Paper and Memphis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Memphis Pharmaceuticals and Universal For is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Universal For Paper are associated (or correlated) with Memphis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Memphis Pharmaceuticals has no effect on the direction of Universal For i.e., Universal For and Memphis Pharmaceuticals go up and down completely randomly.

Pair Corralation between Universal For and Memphis Pharmaceuticals

Assuming the 90 days trading horizon Universal For Paper is expected to under-perform the Memphis Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Universal For Paper is 3.41 times less risky than Memphis Pharmaceuticals. The stock trades about -0.35 of its potential returns per unit of risk. The Memphis Pharmaceuticals is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest  5,444  in Memphis Pharmaceuticals on September 29, 2024 and sell it today you would lose (296.00) from holding Memphis Pharmaceuticals or give up 5.44% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Universal For Paper  vs.  Memphis Pharmaceuticals

Universal For Paper

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Universal For Paper are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical and fundamental indicators, Universal For is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Memphis Pharmaceuticals

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Memphis Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Memphis Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Universal For and Memphis Pharmaceuticals

The main advantage of trading using opposite Universal For and Memphis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Universal For position performs unexpectedly, Memphis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Memphis Pharmaceuticals will offset losses from the drop in Memphis Pharmaceuticals' long position.

The idea behind Universal For Paper and Memphis Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.